{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:33:09Z","timestamp":1773909189742,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:00:00Z","timestamp":1794960000000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS114404"],"award-info":[{"award-number":["NS114404"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neulet.2025.138443","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:29:02Z","timestamp":1763083742000},"page":"138443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Limited effects of the REV-ERB agonist SR9009 after mouse spinal cord contusion: Reduced acute pathology with unaffected functional recovery and chronic white matter loss"],"prefix":"10.1016","volume":"870","author":[{"given":"Lukasz P.","family":"Slomnicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Morehouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata Saraswat","family":"Ohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Burris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-8478","authenticated-orcid":false,"given":"Michal","family":"Hetman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2025.138443_b0005","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neulet.2025.138443_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213339","article-title":"The proteostasis network: a global therapeutic target for neuroprotection after spinal cord injury","volume":"11","author":"Whittemore","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neulet.2025.138443_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113704","article-title":"Neuroimmunological therapies for treating spinal cord injury: evidence and future perspectives","volume":"341","author":"Chio","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2025.138443_b0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd4100","article-title":"REV-ERB and ROR nuclear receptors as drug targets","volume":"13","author":"Kojetin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neulet.2025.138443_b0025","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"5102","article-title":"Circadian clock protein Rev-erbalpha regulates neuroinflammation","author":"Griffin","year":"2019"},{"key":"10.1016\/j.neulet.2025.138443_b0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"Solt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2025.138443_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1102567","article-title":"Rev-erbalpha agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway","volume":"14","author":"Sheng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neulet.2025.138443_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115067","article-title":"Time of day dependent reduction in stroke infarct volume by the Reverb agonist SR9009 in mice","volume":"384","author":"Kamat","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2025.138443_b0045","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s11064-023-03872-5","article-title":"Circadian rhythm regulator REV-ERBalpha attenuates neuroapoptosis in early brain injury after experimental subarachnoid hemorrhage in rats","volume":"48","author":"Lu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2025.138443_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-020-1718-7","article-title":"Decreased expression of Rev-Erbalpha in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbalpha have anti-inflammatory and neuroprotective effects in the pilocarpine model","volume":"17","author":"Yue","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2025.138443_b0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12974-022-02494-y","article-title":"The circadian clock protein Rev-erbalpha provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome","volume":"19","author":"Kou","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neulet.2025.138443_b0060","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1016\/j.celrep.2018.11.101","article-title":"REV-ERBalpha regulates TH17 cell development and autoimmunity","volume":"25","author":"Amir","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neulet.2025.138443_b0065","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"18528","article-title":"The nuclear receptor REV-ERBalpha modulates Th17 cell-mediated autoimmune disease","author":"Chang","year":"2019"},{"key":"10.1016\/j.neulet.2025.138443_b0070","article-title":"Targeting circadian protein rev-erbalpha to alleviate inflammation, oxidative stress, and enhance functional recovery following brain trauma","volume":"13","author":"Darmanto","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.neulet.2025.138443_b0075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbi.2019.01.014","article-title":"Stimulation of nuclear receptor REV-ERBs suppresses production of pronociceptive molecules in cultured spinal astrocytes and ameliorates mechanical hypersensitivity of inflammatory and neuropathic pain of mice","volume":"78","author":"Morioka","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neulet.2025.138443_b0080","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-019-0497-x","article-title":"Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module","volume":"22","author":"Munji","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2025.138443_b0085","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/neu.2006.23.635","article-title":"Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains","volume":"23","author":"Basso","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neulet.2025.138443_b0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/exnr.1996.0098","article-title":"Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection","volume":"139","author":"Basso","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2025.138443_b0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exnr.1999.7016","article-title":"Comparing deficits following excitotoxic and contusion injuries in the thoracic and lumbar spinal cord of the adult rat","volume":"156","author":"Magnuson","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2025.138443_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249591","article-title":"Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery","volume":"16","author":"Wei","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2025.138443_b0105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/089771501300227314","article-title":"Cyclosporin a treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing","volume":"18","author":"Rabchevsky","year":"2001","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neulet.2025.138443_b0110","article-title":"Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia","volume":"7","author":"Silver","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.neulet.2025.138443_b0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00401-019-01992-3","article-title":"The origin, fate, and contribution of macrophages to spinal cord injury pathology","volume":"137","author":"Milich","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neulet.2025.138443_b0120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41467-019-08446-0","article-title":"Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury","volume":"10","author":"Bellver-Landete","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2025.138443_b0125","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2015.03.070","article-title":"Suppression of atherosclerosis by synthetic REV-ERB agonist","volume":"460","author":"Sitaula","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2025.138443_b0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.12.019","article-title":"Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice","volume":"154","author":"Pourcet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.neulet.2025.138443_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105216","article-title":"Stimulation of nuclear receptor REV-ERBs suppresses inflammatory responses in spinal microglia","volume":"151","author":"Morioka","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2025.138443_b0140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41467-021-21477-w","article-title":"Dysregulation of REV-ERBalpha impairs GABAergic function and promotes epileptic seizures in preclinical models","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neulet.2025.138443_b0145","doi-asserted-by":"crossref","unstructured":"E. Esposito, W. Li, T.M. E, J.H. Park, I. Sencan, S. Guo, J. Shi, J. Lan, J. Lee, K. Hayakawa, S. Sakadzic, X. Ji, E.H. Lo, Potential circadian effects on translational failure for neuroprotection, Nature 582 (2020) 395-398. https:\/\/doi.org\/10.1038\/s41586-020-2348-z.","DOI":"10.1038\/s41586-020-2348-z"},{"key":"10.1016\/j.neulet.2025.138443_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249981","article-title":"Limited changes in locomotor recovery and unaffected white matter sparing after spinal cord contusion at different times of day","volume":"16","author":"Slomnicki","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2025.138443_b0155","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1523\/JNEUROSCI.0003-06.2006","article-title":"Activated microglia contribute to the maintenance of chronic pain after spinal cord injury","volume":"26","author":"Hains","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2025.138443_b0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi3259","article-title":"Microglia promote maladaptive plasticity in autonomic circuitry after spinal cord injury in mice","volume":"16","author":"Brennan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neulet.2025.138443_b0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbi.2015.08.009","article-title":"Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury","volume":"51","author":"Maldonado-Bouchard","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neulet.2025.138443_b0170","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nm.3213","article-title":"Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy","volume":"19","author":"Woldt","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2025.138443_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46292\/sci20-00067","article-title":"Pathophysiology of neurogenic obesity after spinal cord injury","volume":"27","author":"Gater","year":"2021","journal-title":"Topics in Spinal Cord Injury Rehabilitation"},{"key":"10.1016\/j.neulet.2025.138443_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102598","article-title":"Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: a systematic analysis for the Global Burden of Disease 2021 study","volume":"103","author":"Lu","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neulet.2025.138443_b0185","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1038\/s41598-020-71131-6","article-title":"Improved locomotor recovery after contusive spinal cord injury in Bmal1(-\/-) mice is associated with protection of the blood spinal cord barrier","volume":"10","author":"Slomnicki","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025003325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394025003325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:21:45Z","timestamp":1773894105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394025003325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S0304394025003325"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138443","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited effects of the REV-ERB agonist SR9009 after mouse spinal cord contusion: Reduced acute pathology with unaffected functional recovery and chronic white matter loss","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2025.138443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138443"}}